Uppsala Innovation Day 2024! If you are here come and talk to us about our solution for rapid detection of infectious disease!
Readily Diagnostics
Medicinska och diagnostiska laboratorier
Uppsala, Uppsala County 807 följare
Developing rapid diagnostics
Om oss
Readily Diagnostics develops sensitive, specific and rapid diagnostic testing for infectious disease. The company was founded 2022 based on research done by Dr Liza Löf, PhD in molecular medicine in Professors Masood Kamali-Moghaddam and Ulf Landegrens laboratories at the Department if Immunology, Genomics and Pathology at Uppsala University.
- Webbplats
-
www.readilydiagnostics.com
Extern länk för Readily Diagnostics
- Bransch
- Medicinska och diagnostiska laboratorier
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Uppsala, Uppsala County
- Typ
- Privatägt företag
Adresser
-
Primär
Få vägbeskrivning
Husargatan 3
D7:5
Uppsala, Uppsala County 752 37, SE
Anställda på Readily Diagnostics
Uppdateringar
-
We are happy to welcome William Göransson as a new member of the Readily team! William takes the position of Research Engineer Production and brings great skills and knowledge in biotechnology and reagent manufacturing. William holds a M.Sc. in Molecular Biotechnology Engineering and is a valuable member in our R&D and our new Production team. "I am so excited that William is a part of Readily - with his skills he will contribute significantly to help Readily bring cost-effective diagnostics to the market. Welcome William to the family!", says CEO Liza Löf (Mokvist).
-
-
We are indeed excited! This will help us move faster towards bringing diagnostics to where it is needed!
A new round of BIO-X Accelerate is now commencing. We are pleased to welcome five selected companies: ArgusEye, Phenaros Pharmaceuticals, Rarity Bioscience , Readily Diagnostics, and Strike Pharma AB. Last in line to presented is the company Readily Diagnostics. Readily Diagnostics' technology is based on padlock probes and rolling circle amplification (RCA), combined with a proprietary solution to enhance speed. It integrates a molecular method with microfluidics, allowing for use in various settings or with standard laboratory equipment for high throughput. This technology offers the robustness and specificity of RT-PCR without requiring specialized instruments. "We are incredibly excited and honored to have been selected for the BIO-X Accelerate program! We see this as validation that our diagnostic tests will make a significant difference in healthcare. With the support of BIO-X Accelerate, we can now take further steps to develop our clinical test, advance our regulatory journey towards CE-IVD certification, and offer it to healthcare providers more quickly." — Liza Löf (Mokvist), PhD, CEO. Are you an investor looking for new and exciting Life Science companies? Sign up for the BIO-X Accelerate Kickoff and Investment Meeting to meet Readily Diagnostics and nine other pitching companies. Register here: https://lnkd.in/diurc_gd Funding is available through European Regional Development Fund (ERDF) administered by The Swedish Agency for Economic and Regional Growth (Tillväxtverket).
-
-
We are thrilled to announce that our CEO and co-founder has won the prestigious SKAPA Prize at Uppsala län’s länsfinal 2024! This recognition is a significant milestone for us and will contribute to our efforts in bringing our first product into test sales in Q4 2024. 🌟 Our innovative padlock probe technology is poised to make a substantial impact in healthcare by providing timely and precise results directly at the point of care. We will be validating our product for research use in an customer environment in Q4 2024. Stay tuned for more updates as we work towards making a lasting, positive difference in the healthcare industry. #HealthcareInnovation #Diagnostics #BioXAccelerate #LifeSciences #PatientCare #MedicalTechnology #ReadilyDiagnostics
Ett stort grattis till årets vinnare av SKAPA-priset 2024: Liza Löf, vd på Readily Diagnostics 🏆 Titta på filmen för att se Liza berätta om sin innovation.
-
We want to welcome Simone Bergqvist to the Readily team as our new Laboratory Engineer/QC! Simone holds a Master of Science in Molecular Medicine and with her great laboratory skills will help us bring our rapid technology for detection of infectious disease faster to the market! Simone will be a valuable member of our growing R&D team. “I am so happy that Simone is joining us. She will be a great addition to the Readily team and will contribute to our exciting next steps in bringing our products to the market. Welcome to the family, Simone!” 🤩 Liza Löf (Mokvist)
-
-
We are at ADLM in Chicago! Looking forward to nice discussions and see what is new and exciting! Contact our CEO Liza Löf (Mokvist) if you want to talk more about our rapid diagnostic platform for infectious disease! See you there!
-
-
🚀 We are thrilled to announce that Readily Diagnostics has been awarded funding from the Bio-X Accelerate Program! This support will enable us to further develop and introduce our next-generation rapid diagnostic tests for respiratory diseases, significantly improving patient care with faster and more accurate diagnostics. 🌟 Our innovative padlock probe technology is set to revolutionize healthcare by providing timely and precise results directly at the point of care. Stay tuned for more updates as we work towards making a positive impact in the healthcare industry. BIO-X Accelerate is a program with the goal of accelerating the development of innovation in the health and/or life science industry. The program uses an industrial approach to support life science-related projects that could fulfill well-defined needs and create IMPACT in healthcare, industry and society. Selected companies receive funding for their projects as well as continued support and access to experts within the BIO-X network. BIO-X Accelerate with the theme IMPACT is a project by STUNS with strategic partners UIC, Connect Uppsala, Create Business Incubator, Lead (Business Incubator), Inkubera and supporting partners Linköping University Innovation, Uppsala University and Örebro University Holding. The project is financed by European Regional Development Fund (ERDF) through The Swedish Agency for Economic and Regional Growth via STUNS. STUNS is the foundation for collaboration between the universities in Uppsala, business and society. STUNS Life science is a strategic hub for collaboration between private and public actors to contribute to sustainable knowledge-based growth - in life science, health and neighboring disciplines. #HealthcareInnovation #Diagnostics #BioXAccelerate #LifeSciences #PatientCare #MedicalTechnology #ReadilyDiagnostics
-
-
We congratulate our super-students Anja Håkansson and William Göransson to a great presentation of their thesis! We are so happy that you did your project with us! You both are amazing!
-
-
What a wonderful price to receive! 🤩 True value!!
Almi Invest portföljbolag Readily Diagnostics vinner det fina Bona Postulata-priset. Bra jobbat Liza Löf (Mokvist) och teamet!
-
-
Läs om vårt spännande Readily! Tveka inte att kontakta oss om ni vill veta mer kring vad vi kan erbjuda idag inom snabbdiagnostik!
Readily Diagnostics utvecklar nytt snabbtest med hög känslighet 👩🏼🔬🧪 Snabbtestet som har samma höga känslighet som dagens PCR-tester. Tekniken är ursprungligen utvecklad av forskare på Ulf Landegren lab i Uppsala och baseras på padlock probes eller så kallade hänglåsprober. En teknik som sedan utvecklats vidare till ett robust och känsligt snabbtest av Liza Löf (Mokvist), forskare och VD vid Readily – bolaget som nu fokuserar på att ta testet vidare till nytta ute i samhället. Läs hela artikeln 👇🏽